Enwei Pharmaceutical Co., Ltd. (SHE:301331)
21.90
-0.29 (-1.31%)
At close: Jun 11, 2026
-30.30% (1Y)
| Market Cap | 2.23B -13.0% |
| Revenue (ttm) | 879.60M +6.6% |
| Net Income | 48.14M +6.1% |
| EPS | 0.46 +2.7% |
| Shares Out | 101.88M |
| PE Ratio | 47.24 |
| Forward PE | n/a |
| Dividend | 0.66 (2.97%) |
| Ex-Dividend Date | May 28, 2026 |
| Volume | 1,625,604 |
| Open | 22.04 |
| Previous Close | 22.19 |
| Day's Range | 21.52 - 22.41 |
| 52-Week Range | 21.52 - 39.66 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |